This paper contributes to the emerging Bayesian literature on treatment effects by deriving treatment parameters in the framework of a potential outcomes model with a latent factor structure. This approach has attractive features from both theoretical and practical points of view. Not only does it naturally address the fundamental identification problem due to the unobserved correlation between the potential outcomes, but it also turns out to be very simple to implement and to produce reliable results. Full technical details are provided to compute mean treatment effects as well as their distributional versions, and a simple Monte Carlo simulation study is carried out to illustrate how the methodology can easily be applied.
Introduction
The estimation of treatment effect parameters has attracted a great deal of attention in the econometric literature on program evaluation because of their policy relevance. Frequentist approaches have been the focus of a large number of theoretical papers (Imbens and Wooldridge, 2009; Heckman and Vytlacil, 2007a,b; Abbring and Heckman, 2007) , and have been fruitfully applied to questions in labor, education and health economics. 1 This interest is, however, not reflected in the Bayesian literature, where only a few papers have been published compared to the huge body of research in the classical literature, and where empirical applications of the proposed methods are scarce. This paper discusses several explanations for the lack of interest in treatment effects on the Bayesian side. We then provide technical details to derive and compute a large array of treatment effect parameters in the framework of a potential outcomes factor structure model that directly tackles the problems of the existing Bayesian approaches, and is therefore likely to be more useful in practice.
The well-known fundamental problem in program evaluation derives from the fact that people can never be observed in different treatment states simultaneously, which makes it is impossible to directly observe their outcome gains. To deal with this issue, some classical approaches rely on conditional independence assumptions that posit a small vector of observed and possibly unobserved personal characteristics explaining all the correlation between treatment status and outcomes in the different states.
Matching methods have become very popular in this field (Cochrane and Rubin, 1973; Rosenbaum and Rubin, 1983) . See the survey in Heckman and Vytlacil (2007b) . Bayesian approaches to date have been based on different strategies that, unfortunately, turn out to be problematic in practice. Some of them only allow analysts to derive mean treatment effects and are thus of limited relevance for policy analyses, where joint distributions of potential outcomes often provide more insights into the effectiveness of programs. (See Abbring and Heckman, 2007 .) It is often more informative to learn what proportion of a population benefits from a program, or to identify how some target groups are affected by it, rather than just measuring mean effects that do not reveal the heterogeneity of the impact of the program (Heckman et al., 1997; Abbring and Heckman, 2007) . Other approaches are based on special assumptions of limited generality in application.
This paper contributes to the current literature by showing how treatment parameters can be computed in a Bayesian fashion for a potential outcomes model with a factor structure that is easy to implement. Latent factors are introduced to explain the unobserved correlation between the determinants of treatment status and the potential outcomes. As noted by Carneiro et al. (2003) , this type of model generalizes the method of matching and can be used to derive mean treatment effects as well as distributional versions. The standard model used throughout this paper can be extended to more flexible functional forms and distributional assumptions.
The paper is organized as follows. Section 2 briefly introduces the potential outcomes model based on the Generalized Roy model and discusses the different ways the fundamental identification problem has been addressed in the Bayesian literature. By weighing the advantages and disadvantages of the different approaches, it becomes clear why the potential outcomes factor structure model represents an attractive approach to this problem. Section 3 provides full technical details about the derivation of the treatment effect parameters, with both their mean and distributional versions. We will focus our attention on three popular treatment parameters, namely the Average Treatment Effect (ATE), the effect of Treatment on the Treated (TT), and the Marginal Treatment Effect (MTE). 2 Section 4 explains how to apply this approach in practice to compute the treatment parameters. A simple Monte Carlo study illustrates and compares the performances of the different proposed estimators. Section 5 finally concludes with some remarks about useful directions for future research.
Potential Outcomes Model and Identification Issues 2.1 The baseline model and its fundamental identification problem
The textbook model considered in this paper is an extension of the original Roy model (Roy, 1951; Heckman and Honoré, 1990) and assumes a binary treatment decision D that involves two continuous potential outcomes Y 1 and Y 0 for the treated and untreated states, respectively:
where 1(·) denotes the indicator function that is equal to 1 if the corresponding condition is fulfilled, and equal to 0 otherwise. 3 The relationship of the Roy model to other models of potential outcomes is discussed in Heckman (2008) . The treatment decision is specified as a standard threshold-crossing model, where the utility associated with taking treatment depends linearly on some observed characteristics Z through the vector of slope parameters γ. The two potential outcomes are assumed to linearly depend on a set of covariates X through the vectors of slopes β 1 and β 0 . Without any loss of generality, these covariates are assumed to be common across states. The presence of at least one exclusion restriction-or instrument-is assumed in the treatment equation, hence the use of the notation Z for the covariates that differ from X in the outcome equations. Note, however, that this assumption is not strictly required in the remaining of this paper, since we rely on a parametric specification of the model. Exclusion restrictions would be necessary to achieve nonparametric identification, without specifying any restrictions on functional forms. 4 Unobserved heterogeneity is captured by the error terms U D , U 1 and U 0 , which are assumed to have zero means and finite variances.
Since a person can only be in one specific treatment state, the actual outcome Y is observed according to the following rule:
(See Quandt, 1958.) In the program evaluation literature, the main parameter of interest is the outcome gain defined as ∆ ≡ Y 1 − Y 0 . Consequently, for each individual present in state j (j = 0, 1), the challenge is to identify her potential outcome in the alternative state. The unobserved outcome is usually called a counterfactual outcome, and the estimation of its distribution has raised a great deal of interest in econometrics (Carneiro et al., 2003; Chernozhukov et al., 2009) .
A naive approach to solving this missing data problem would be to simply compare outcomes in the two treatment groups. Such an approach could, however, ignore the underlying selection process, and thus yield biased treatment parameters. The observed characteristics X and Z often explain a small part of the heterogeneity of the treatment decision and of the potential outcomes Y 0 and Y 1 . Other personal characteristics, unobserved to the econometrician, are captured by the error terms U D , U 1 and U 0 . A prototypical example is personal abilities: individuals with higher abilities often perform better, whatever choice they 3 See Heckman (1990) for one discussion of the more general Roy model and its identification. Heckman and Vytlacil (2007b) provide a general discussion.
4 Heckman (1990) and Heckman and Vytlacil (2007b) present conditions for nonparametric identification of the model. make. If the treatment decision is achieving higher education, and the outcome of interest is a labor market outcome, high-skilled individuals will more likely achieve higher education than less-skilled individuals and earn higher outcomes, even if they actually fail to succeed in school. This implies a positive correlation between the error terms of the different equations.
To complete the specification of the potential outcomes model, and better understand the consequences of the fundamental identification problem, the covariance structure of the unobserved part of the model can be expressed as:
where ρ rs ≡ Corr(U r , U s ). The variance of U D is set to 1 for identification of the binary choice equation. Obviously, since Y 1 and Y 0 can never be observed simultaneously for a given person, the correlation ρ 10 cannot be inferred from the data. Heckman (1992) and Vijverberg (1993) were the first to highlight this problem, which arises in all models with state-dependent outcomes (the Roy model and its extensions). It has been tackled (or ignored) in two different strands in the Bayesian literature. On the one hand, learning about the non-identified parameter ρ 10 can take place during the estimation process and be exploited to derive mean treatment effects as well as their distributional versions. On the other hand, the problem can be avoided by estimating the model without the joint distribution of the potential outcomes. This solution bypasses the identification problem, but also makes it impossible to go beyond mean treatment parameters (Section 2.2).
The approach adopted in this paper uses factor structure models, defined in Section 2.3, and enables analysts to estimate a wide array of mean and distributional treatment effects. Although this topic has been extensively treated in the classical literature (Abbring and Heckman, 2007) , to the best of our knowledge no attempts have been made so far to propose a formal presentation of the treatment effects from a Bayesian perspective. In principle it is possible to develop a nonparametric version of our analysis but we do not do so in this paper.
Dealing with the non-identified correlation between the potential outcomes
Learning about ρ 10 . Vijverberg (1993) points out that although the correlation parameter ρ 10 is not identified, it cannot take any possible values in the interval [−1, 1] since the covariance matrix in Equation (2) has to be positive semidefinite. This constraint is fulfilled if and only if the determinant of the covariance matrix is positive, which leads to the following bounds on the non-identified correlation:
Since the data are informative about the identified correlation parameters ρ D1 and ρ D0 , Equation (3) provides a vehicle for learning about ρ 10 . Among other contributions, Heckman et al. (1997) extend these results to nonparametric settings using the Fréchet-Hoeffding bounds. Koop and Poirier (1997) , as well as Poirier (1998 ), complete Vijverberg (1993 's analysis by showing that the learning taking place about the non-identified correlation parameter is actually driven by the prior dependence between the identified and non-identified parameters. Prior and posterior marginal distributions need not be identical, because "data information on the identified parameters 'spills-over' to the non-identified parameter if the two groups are a priori dependent" (Koop and Poirier, 1997, p. 218) . However, prior beliefs about ρ 10 are not updated by the data conditional on ρ D1 and ρ D0 . The learning process only operates through the bounds derived in Equation (3).
The support restrictions can be more or less informative about the range of ρ 10 , depending on how tight the bounds are. Unfortunately, this problem can only be assessed on a case-by-case basis. Three empirical examples drawn from published research are re-analyzed in Vijverberg (1993) and it appears that in some cases, it is possible to actually learn about the magnitude and/or the sign of the unobserved correlation. 5 Poirier and Tobias (2003) present different sets of results from synthetic data showing that the bounds sometimes convey a lot of information and make it possible to accurately approximate ρ 10 and sometimes turn out to be completely uninformative about this parameter. Interestingly, they note that "researchers will know when the support restrictions provide information about the unidentified parameter, because this can be determined from the identified correlation coefficients" (Poirier and Tobias, 2003, p. 263) .
A further issue concerns the choice of the prior on the restricted support. Since learning only takes place about the bounds of the non-identified correlation, and the data remain silent about the correlation parameter within these bounds, the prior has a clear influence on any inference about ρ 10 . Vijverberg (1993) , Koop and Poirier (1997) , and subsequent papers employ a uniform prior over the interval [ρ 10 , ρ 10 ] for ρ 10 , conditional on ρ D1 and ρ D0 , and a uniform prior over [−1, 1] for these latter parameters. These priors are thus vague within the bounds and guarantee that the covariance matrix is positive semidefinite. Specifying more informative priors might significantly affect the results, "as the prior will affect the location and shapes of the posteriors within the conditional supports" (Tobias, 2006, p. 14) . Poirier and Tobias (2003) establish the same conclusion with a simulation study.
The extended Roy model appears as a natural framework within which to explore how constraints on the covariance matrix make it possible to learn about the non-identified correlation between the potential outcomes. This approach can be generalized to any type of model where one or more non-identified parameters are a priori not independent of some other identified parameters. For example, similar to the cases derived in Vijverberg (1993) 's appendix, Tobias (2006) uses a four-potential-outcome model and investigates the sources of learning about the four non-identified cross-regime correlation coefficients. He shows that learning about the unobserved correlations can take place through the exact same mechanism as in the single-outcome case. However, complications arise with the learning about partial correlations, inasmuch as the support of some of these partial correlations cannot be restricted.
Bayesian approaches to estimating the distribution of outcome gains in the presence of non-identified parameters has been the subject of several papers, including Poirier and Tobias (2003) ; Li et al. (2004) ; Tobias (2006) ; Li and Tobias (2008) . Once the range of ρ 10 has been pinned down through the support restrictions, no complications arise in the derivation of the different treatment effects. In cases where the learning mechanism fails to point identify the correlation through information in support restrictions, an informative prior has to be placed on the correlation parameter in order to be able to compute distributional treatment effects. This solution is unsatisfactory as it is usually difficult in practice to have well-defined prior beliefs about this unobserved correlation.
Estimating the model without the joint distribution of potential outcomes. As noted in Vijverberg (1993) , the likelihood function does not contain any information about the correlation between the potential outcomes (Y 1 , Y 0 ). Only the joint distributions of both (U D , U 1 ) and (U D , U 0 ) are actually needed to estimate the selection model (Heckman, 1990) . Building on this idea, Chib (2007) develops an alternative approach where the joint distribution of the potential outcomes is not required to analyze the treatment model. Since either pair
) is observed for each individual i, it is possible to estimate the model by specifying only the joint distributions of (U D , U 1 ) and (U D , U 0 ). This approach is straightforward to implement using standard MCMC methods, 6 and bypasses the assumptions required to identify the joint distribution of the potential outcomes and the resulting need to specify an informative prior for their non-identified correlation. However, a direct consequence of this approach is that it is impossible to go beyond mean treatment effects and to compute distributional treatment effects, thus limiting interest in the approach.
Distributional treatment parameters have a particular policy relevance. They make it possible to go beyond mean treatment effects by providing a more complete picture of the impact of the treatment. For example, the average treatment effect E[∆] of a given program can be equal to zero in two distinct cases: Either the program under study has absolutely no impact, or the proportion of the population that benefits from the program is equal to the proportion that suffers from it (Conti and Heckman, 2010 , provide examples of such cases). Computing the distribution of outcome gains would uncover this phenomenon, while mean treatment effects would not reveal it (Heckman et al., 1997; Heckman and Smith, 1998; Aakvik et al., 2005) . Identifying fractions of the population that benefit or suffer from a given treatment can be of crucial importance in applications, e.g. in health economics (see, for instance, Conti et al., 2011) .
Potential outcomes model with a latent factor structure
Restricting the structure of Cov
can produce identification. In particular, specifying a model with underlying latent factors for the error terms can solve the problem of constructing the distribution of treatment effects (see Carneiro et al., 2003; Aakvik et al., 2005; Abbring and Heckman, 2007) . The latent factors are assumed to explain all of the correlation between the different observed variables, including the correlation between the potential outcomes. Providing the dimensionality of the number of factors is restricted, the covariance matrix of the error terms is fully identified by the latent structure of the model. This approach is used in the empirical literature. It solves the identification problem in a very simple way. In addition, in many cases the latent factors play an important role in the model, as they are assumed to capture some specific features of interest. For example, in the growing economic literature on cognitive and noncognitive abilities, such models have been extensively used to capture the effects of latent cognitive ability and personality traits on educational choices, labor market outcomes, social outcomes, and healthrelated outcomes (Carneiro et al., 2003; Hansen et al., 2004; Heckman et al., 2006 Heckman et al., , 2010 Conti et al., 2011) .
We assume that a vector of K latent factors θ drives the unobserved correlation between the different outcomes of interest in Equation (1):
where the error terms are assumed to be centered,
, and mutually independent, ε D ⊥ ⊥ ε 1 ⊥ ⊥ ε 0 . Separability between observables and unobservables is assumed. It is further assumed that (θ, ε) ⊥ ⊥ (Z, X). The latent factors θ are also assumed to be centered, E[θ] = 0, and to have a covariance matrix V [θ] = Σ θ . 7 All of the dependence between the unobservables of the model is driven by the latent factors θ. Carneiro et al. (2003) show how this factor structure framework generalizes the method of matching, by allowing some or all of the variables that generate the conditional independence assumed in matching to be unobserved by the researcher. Another benefit is that the distributions of counterfactual outcomes, which are of major interest in economic studies, are straightforward to construct in this model.
A model with discrete potential outcomes would not be more complicated to handle. Consider for instance the dichotomous outcome case treated in Aakvik et al. (2005) , where for j = 0, 1:
In this case, the outcome gain can take three distinct values, indicating if the individual benefits from the treatment (∆ = 1), suffers from it (∆ = −1) or is indifferent (∆ = 0). Other types of discrete outcomes can be considered as well (e.g., Li and Tobias, 2008 , focus on ordered potential outcomes). Further assumptions and restrictions are required to identify the latent structure of the model. In many empirical applications, additional information can be exploited for this purpose. Abbring and Heckman (2007) review different identification strategies, including approaches based on the availability of a single proxy measure (e.g., a test score), of several measurements with or without choice data (Hansen et al., 2004; Heckman et al., 2006) , or of panel data on outcomes (Carneiro et al., 2001 (Carneiro et al., , 2003 Cunha et al., 2004 Cunha et al., , 2006 . The case where proxy variables are available is of particular interest, since these variables allow the researcher to provide a meaningful interpretation to the factors, depending on their mapping with the measurements.
Assuming that the latent factors θ can be measured by Q continuous variables M = (M 1 , . . . , M Q ) , the following system can be added to the model:
where Λ = (λ 1 , . . . , λ K ) is a (Q × K)-dimensional matrix of factor loadings, and ε is a Q-dimensional vector of error terms that are assumed to be mutually independent, independent of the factors and of the covariates (ε ⊥ ⊥ θ ⊥ ⊥ X), to have zero means and finite variances, i.e., E[ε] = 0 and
). The covariance structure of the latent part of the measurement system is:
where the covariance matrix of the factors Σ θ can be very general at this point, allowing for correlated components of the vector θ. The observation of the correlation between the measurements makes it possible to extract ΛΣ θ Λ , but how to uniquely identify Λ and Σ θ ? There is a fundamental indeterminacy problem, since for any arbitrary nonsingular matrix R of dimension (K × K), the covariance structure is unchanged after assigning Λ = ΛR and Σ θ = R −1 Σ θ . Assuming mutual independence of the factors (i.e., Σ θ diagonal) only partially solves this problem, since the system remains the same by choosing any arbitrary orthogonal matrix such that R −1 = R for the transformation. This is the well-known rotation problem (see Anderson and Rubin, 1956 ). To solve the rotation problem and achieve identification, appropriate restrictions have to be made on the factor loadings matrix and/or on the covariance matrix of the latent factors. One solution is to assume that Σ θ is diagonal and that some measures are dedicated, i.e., one component of θ is associated with a block of measurements on M . The scale of each factor is set by fixing one loading to a given value, for example to 1. This solution is particularly appealing in psychology, where factors are often postulated to be independent. This approach has been widely and successfully implemented in the empirical economic literature on personal abilities and personality traits, where proxy variables provided by psychometric tests are related to well-defined psychological constructs (examples can be found in Carneiro et al., 2001 Carneiro et al., , 2003 Hansen et al., 2004; Heckman et al., 2006 Heckman et al., , 2010 Conti et al., 2011) . Many other solutions exist to the factor rotation problem. For example, Geweke and Zhou (1996) show that a block lower triangular factor loadings matrix, assumed to be of full rank, with strictly positive diagonal elements, and associated with independent standard normal factors (Σ θ = I k ), rule out any rotation (this solution has been adopted by Lopes and West, 2004; Frühwirth-Schnatter and Lopes, 2010; Conti et al., 2011) . With the identification of the latent structure of the measurement system in hand, it is straightforward to identify the factor loadings of the outcome system in Equation (4) from the observed covariance between measurements and outcomes.
The measurement system in Equation (5) can easily be extended to accomodate mixed continuous and discrete measurements (see Carneiro et al., 2003, and Abbring and Heckman, 2007) . This is particularly useful in practice, where psychometric tests often provide a small number of possible answers to a given question (e.g., Likert scales). In this case, the variables in M corresponding to discrete measurements can be regarded as latent, and the observed variables are then obtained through the specification of a thresholdcrossing mechanism. This introduces no further complications with identification other than the standard normalization assumptions used in discrete data analysis and is straightforward to implement.
The identification strategy can be extended to the nonparametric case as well. Under some regularity conditions and support assumptions, the distribution of the latent factors θ and of the error terms ε can be nonparametrically identified. See Cunha et al. (2010) .
For specificity, normality assumptions are adopted for the distributions of the error terms not arising from θ:
As for the factors θ, no particular distributional assumptions are made at this point, so as to remain as general as possible. We just assume that they are centered and have finite variances, and that their distribution function is parameterized by a vector ψ θ . 8 The normal case will be considered in Section 3.2, and other more general distributional forms will be discussed in Section 3.1. The overall model consists of the set of parameters
, ψ θ ) and of the latent variables D and θ, for which prior beliefs can be updated by the application of Bayes' rule after the observation of the data = (D, Y, M, Z, X).
Deriving Treatment Effects
The potential outcomes factor structure model derived in Equation (4) can be used to estimate a wide variety of treatment parameters, with both their distributional and mean versions. In this paper, we focus on the Average Treatment Effect (ATE), which is the expected outcome gain from the treatment for a randomly chosen individual, the effect of Treatment on the Treated (TT), which is the expected outcome gain for an individual randomly chosen from the subgroup of people who are actually treated, and the Marginal Treatment Effect, which is the expected outcome gain for an individual with a given value of unobservables U D . These treatment effects are most commonly invoked and have wide applicability in the empirical literature. They represent a simple case to study in order to explain the methodology that can easily be extended to estimate other treatment parameters. 9 Let the outcome gain be defined as ∆ ≡ Y 1 − Y 0 . Distributional treatment effects are formally defined in Aakvik et al. (2005) . Following their notation, let A be any measurable set, and 1 A (ζ) be the indicator function for the event ζ ∈ A. The distributional versions of the treatment effects corresponding to ATE, TT and MTE can then be defined for a given set of covariates x and z, respectively, as:
This very general definition of the distributional treatment effects allows the derivation of a broad range of treatment parameters. Depending on the goals of the analyst and on the questions to be adressed, the specification of the set A determines the types of treatment parameters that can be inferred. For example, if A = [0, +∞), Equation (7) becomes Pr(∆ > 0|X = x) and measures the proportion of people, at a level of covariates x, who benefit from the treatment. Similarly, Pr(∆ > 0|D = 1, Z = z, X = x) obtained from Equation (8) with the same set A measures the proportion of people taking the treatment who benefit from it (see Heckman et al., 1997) . The conventional mean treatment effects are obtained likewise by averaging the outcome gains:
Since the different versions of the treatment effects defined in Equations (7) to (12) are derived from the conditional distributions of the outcome gain, the first step of the analysis consists of recovering these distributions:
In Section 3.1, we derive these distributions and the corresponding treatment effects. Mean treatment parameters are presented along with their distributional versions. More specifically, we work the example Pr(∆ > 0|X) in the overall population, and also in the treated population and at different margins of taking treatment. Contrary to mean treatment effects, distributional treatment effects can only be derived with the joint distribution of the potential outcomes in hand, which is straightforward to achieve in the framework of our factor structure model.
The conditional approach to derive the treatment effects
This section introduces general formulae for the derivation of the treatment effects conditional on the latent factors. The framework is very flexible and can be extended to accommodate more general distributional and functional forms. The treatment effects are derived for given sets of covariates Z and X, which can overlap or not. 10 As a consequence, and to simplify notation, X and/or Z will be dropped from the conditioning sets of the following expressions when they are redundant.
Average Treatment Effect. The average treatment effect and its distributional version are derived from the distribution of the outcome gains. For a given set of covariates x, this distribution is obtained by integrating out the latent factors θ and the model parameters Γ :
where p(Γ ) and p(θ|Γ ) are used to denote the distributions of model parameters and of the latent factors in a very generic way. In a posterior approach, p(Γ ) would be replaced by the posterior distribution p(Γ |data), where Γ is updated after observing the data through the application of Bayes' rule. As for the conditional distribution p(θ|Γ ), we will see in Section 3.3 that the information available to measure the latent factors determines how these factors are integrated out. From Equation (14), the distributional and mean treatment effects read:
Effect of Treatment on the Treated. Similarly, the distribution of the gains in the treated state is expressed as:
where the last line results, after simplification, from the application of Bayes' rule on the conditional distributions of θ and Γ , respectively. The conditioning on D = 1 in the first term of the second expression vanishes because of the conditional independence of the potential outcomes and of the treatment status (the covariates and the factors explain all the dependence, hence ∆ ⊥ ⊥ D | X, θ). Equation (16) can be viewed as a weighted average of the conditional distribution of the outcome gains:
where the weights are:
Distributional and mean treatment effects conditional on taking treatment are derived in the same fashion as the average treatment effect:
TT
Marginal Treatment Effect. Marginal treatment effects are built to the same design as ATE and TT, using the following distribution of outcome gains conditional on unobservables U D :
where the weights are
Distributional and mean treatment effects conditional on unobservables U D then read:
Advantages of the conditional approach. Several features of the conditional approach are worth pointing out:
• From the continuous outcome case to more complicated functional forms. In Section 2.3, trivariate normality of the potential outcomes and of the treatment status conditional on the factors θ was assumed. This implies that the expressions of the treatment effects derived above, which are all weighted average of the expected conditional outcome gains and of their distributions, can be further simplified using the following identities:
where φ(·) and Φ(·) denote, respectively, the probability density function and the cumulative distribution function of the standard normal distribution.
The very general form of the formulae derived in the previous section allows to extend the analysis to more complicated functional forms, such as those for discrete outcomes. For instance, in the dichotomous case (Aakvik et al., 2005) , the probabilities of the three values the outcome gain can take are:
These expressions can then be used to derive the different versions of the treatment effects, including their distributional and mean versions. See Li and Tobias (2008) for the case of ordered outcomes.
• Adding a measurement system facilitates the interpretation of the factors. In some cases, the latent factors capture some theoretical concepts (e.g., personality traits or cognitive abilities, widely used in psychology and more recently in economics) and it might be of interest to analyze how the different treatment effects are distributed along the distribution of these factors.
• Non-normal factors. The normal case presented in the coming Section 3.2 is standard in factor analysis and represents the baseline model of most empirical analyses. Nevertheless, the normality assumption may be too restrictive in practice and result in biased estimators for the factor loadings, which would affect the estimation of the treatment effects. The general approach presented here is not wedded to the normality assumption (see, e.g., Abbring, 2007) . Any distribution that is centered with finite covariance matrix, and that can be easily sampled from, can be used for the latent factors. Common examples include Student-t distributions that allow fatter tails than the normal distribution, and mixtures of normals that make it possible to approximate more peculiar distributions, such as multimodal distributions. Li et al. (2004) derive the predictive distributions of outcome gains for these two alternative distributions of the factors.
• The conditional approach. The flexibility of the conditional approach comes at a cost. In practice, the precision of the estimators for the treatment effects depends on the quality of the numerical integration of the latent factors. This aspect will be illustrated and discussed in Section 4.
Treatment effects in the normal case
Assuming that the latent factors are normally distributed,
the joint distribution of the treatment index D and of the potential outcomes Y 1 and Y 0 is straightforward to derive. In the wake of the analysis conducted in Section 3.1, the conditional distribution is expressed as 11
while the following unconditional joint distribution is implied:
Either expression can be used for the derivation of the likelihood function. However, there are some cases where the analyst might prefer to work with one version or the other. If the latent factors are required to conduct further posterior analysis, then they should explicitly be incorporated into the model (e.g., to investigate how a treatment parameter is distributed along the distribution of a particular factor of interest). On the other hand, if the factors are of secondary importance, then it is preferable to work with the unconditional distribution of Equation (21). The benefit of the latter approach is in simplification of the computation. Since Markov chain Monte Carlo methods simulate the parameters to bypass the problems inherent in performing complicated integrations, any integration that can be performed analytically before the simulation should be carried out. Collapsing of the state space of the algorithm results in more efficient sampling schemes (Liu, 1994; Liu et al., 1994) .
In the framework of the potential outcomes factor structure model, the standard normality of the factors greatly simplifies the problem and leads to closed-form solutions for most treatment effect parameters. For this purpose, the joint distribution of the treatment index and of the outcome gain is easier to work with:
For simplicity, the different versions of the outcome gains distributions and of the treatment parameters are presented conditional on Γ in the sequel.
Distributions of outcome gains. The distributions of outcome gains in the overall population, conditional on taking treatment and conditional on unobservables U D are, respectively:
The ingredients required to derive the distribution of outcome gains conditional on taking treatment are:
Distributional treatment effects. Using general results on the bivariate normal distribution, the distributional treatment parameters read, conditional on a set of model parameters Γ :
where σ ∆ is the standard deviation of the outcome gain and ξ is defined in Equation (23). Unfortunately, there is no tractable solution for the parameter shown in Equation (25), which represents the fraction of the treated population benefiting from treatment. Note however that the double integration can be collapsed to a single integral by reexpressing this parameter as:
where:
Standard Monte Carlo integration methods can then be performed to compute this treatment effect.
Mean treatment effects. The mean treatment parameters read, conditional on a set of model parameters Γ :
where φ(t) /Φ(−t) is the inverse Mills ratio in the formula for TT.
Integrating out model parameters. A naive approach would be to average the different formulae of the treatment parameters derived above as a function of Γ over the posterior distribution p(Γ |data). This approximation might produce accurate results, because we can expect the distributions p(Γ |D = 1, data) and p(Γ |U D = u, data) to mimic pretty closely p(Γ |data). Nevertheless, there is a potential flaw due to the fact that the conditioning on D = 1 and U D = u is omitted in the integration of Γ for TT and MTE, respectively. Li et al. (2004) , as well as Tobias (2006) , note that since these two events involve parameters of Γ , they should be taken into account when the parameters Γ are integrated out. The integration can thus be performed in the same way as in Section 3.1, with respect to the posterior distribution p(Γ |data) and with the following weights for TT and MTE, as well as for their distributional versions:
where
Note that in some applications, it is of interest to infer the treatment effects unconditional on covariates X and Z. Common practice is to use the empirical distribution of the covariates as an approximation to p(X, Z|data). However, if there is selection on the observables X and Z, the distribution p(X, Z|data) will look different than p(X, Z|D = 1, data). An appropriate correction is therefore required in thise case to use the empirical distribution of the covariates.
Available information about the factors, out-of-sample and in-sample treatment effects
Depending on the information available to measure the latent factors, different approaches can be adopted for the estimation of the treatment effects. The first one is a posterior predictive approach that consists of using the model to predict outcome gains for future populations (out-of-sample approach), while the second one infers the outcome gains for the actual individual present in the observed sample (in-sample approach).
Out-of-sample approach. The posterior predictive approach is the mainstream in Bayesian analysis (see, for example, Poirier and Tobias, 2003; Li et al., 2004) . It focuses on the prediction of outcome gains for future populations that are similar to the observed population represented by the data, in terms of observables Z and X and unobservables θ. To derive the treatment effects, it is essential to know what type of information is available about the future individual at the time of the prediction. If both outcomes Y and measurements M are unobserved, the only information that can be exploited to infer θ is the one learned about its distribution (the parameters ψ θ of the factor distribution are updated during the estimation process). The distribution p(θ|Γ ) thus reduces to the posterior distribution of θ obtained from the estimation on the observed sample.
An interesting case arises if the measurements M -all or only a subset of them-are observed along with the covariates X and Z. The sampling procedure of the predictive outcome gains can then be modified to account for this information extracted from the measurement system. Economic examples where this situation happens are numerous in the empirical literature: proxy variables for personality traits and cognitive ability, such as test scores, are often measured during childhood. The goal is to measure the impact of a particular policy program on the outcomes of a future adult using a predictive approach, given that only her personal characteristics X and Z, as well as her measurements M are available. How can this extra information, of particular policy relevance, be taken into account to compute the treatment effects?
Concretely, the measurements of the future individual are introduced into the conditioning set of the distribution of the outcome gains, and the latent factors are predicted from the posterior distribution, conditional on these observed measures. In other words, the posterior obtained from the observed sample is used as future prior for the factors to compute the treatment effects. Using the subscript f to denote the future, as yet unobserved, outcome gains, personal characteristics, and factors, the predictive distribution of ∆ f is:
where, after simplification, m f only appears in the conditional distribution of θ f and thus only serves to derive its posterior predictive distribution. Reading Equation (34) from right to left reveals the updating process at stake: prior beliefs about model parameters Γ are updated after observation of the data; these updated parameters, combined with the observed covariates x f and measurements m f for the in the future individual, make it possible to predict the latent factors θ f ; in turn, all the information derived from these two steps is used to predict the future outcome gain ∆ f . Similar to TT and MTE, this expression can be expressed as a weighted average of the outcome gain distribution:
with the weights:
Intuitively, outcome gain predictions will be given more importance if they are based on sampled latent factors that are good at explaining the observed measurements m f .
In-sample approach. In contrast with the approach presented above, where the person in the future may or may not be in the actual sample but is still assumed to belong to the same population, in this approach we base our analysis on a given person from the observed sample-or even on the whole sample-to compute the treatment effects. In this case, it is possible to make use of her realized treatment status and of her corresponding outcome, rather than predicting them. This approach is, for example, used in Conti et al. (2011) to infer the treatment effects by averaging over the individuals present in the sample. This alternative approach is in the same spirit as classical approaches that rely on a three-step procedure to compute the treatment effects: The measurement system is estimated in the first stage, factor scores are then predicted in the second stage of the analysis, and then plugged in to compute the treatment effects in the third step. Special care is then required to correct for errors in measurement that arise from using predicted factors instead of the true factors .
Estimating Treatment Effects: A Simulation Study
We generate a simple potential outcomes model built to the same design as Equation (4), and compute the different versions of the distributional treatment effects measuring the proportion of the population benefiting from treatment (i.e., in the overall population, in the treated population, and at different margins of taking treatment). The conditional approach on θ as well as the unconditional approach are implemented.
Simulating and estimating an artifical potential outcomes model
The potential outcomes model is simulated with the following parameters for the outcome system: and the latent factor θ is proxied by five continuous measurements generated from the system in Equation ( We consider samples of size N = 500 and N = 5, 000, and simulate 1,000 data sets for each N . Within this framework, the fraction of the population being treated is equal to 0.58, and the true expected outcome gain is equal to 1.50. Since Cov(U D , U 1 − U 0 ) = 1.20, a positive selection on latent gains occurs in this model. To gain insights into the computation of the treatment effects, we perform a Monte Carlo experiment and estimate the model for each of the 1,000 data sets, using a standard Gibbs sampler with noninformative priors: a flat prior N (0, ∞) is assumed for the slope parameters and intercept terms, a normal prior N (0, 10) for the factor loadings, and for the idiosyncratic variance an inverse-gamma prior G −1 (2.11, 1.11) implying a prior mean and standard deviation of 1 and 3, respectively. To improve the mixing of the MCMC chain, parameter expansion is carried out by freeing the variance of the latent factor in the working model (Ghosh and Dunson, 2009) , where the same inverse-gamma prior as for the idiosyncratic variances is used. The parameters are then transformed back to the inferential model where the variance of the factor is fixed to 1, and the first factor loading is constrained to be positive to prevent sign-switching. 10,000 iterations are saved for posterior inference and for the computation of the treatment effects, after a burn-in period of 2,000 iterations. The distributions of the posterior means of the parameters are summarized in Figures 1 and 2 , where it appears that the parameters are overall precisely estimated, especially the factor loadings and the idiosyncratic variances that play a major role in the calculation of the distributional treatment effects.
Computing the treatment effects from the MCMC chains
The Gibbs sampling algorithm used to estimate our potential outcomes model generates, after convergence of the Markov chain, a sample of model parameters Γ (1) , . . . , Γ (M ) from their posterior distributions. This sample can in the end be used to perform a Monte Carlo integration of Γ in the formulae of the treatment effects and of their distributional versions derived in Section 3. For example, the compact forms of the distributional treatment effects in the unconditional approach on θ, which are derived in Equations (24), (26) and (27), can be combined with the corresponding ingredients derived in Equation (28) and the weights in Equations (32) and (33). Averaging these expressions over the post-convergence draws, for a given set of covariates Z = z and X = x, provides: 
, where the probability of benefiting from treatment reads:
In these expressions, the latent factors θ are integrated out simultaneously with model parameters Γ through Monte Carlo integration. Given the distributional assumptions of our simple model and the posterior predictive approach we adopt, this consists of drawing from the standard normal distribution, θ (m) ∼ N (0, 1). In an in-sample approach, these probabilities would be computed for a given individual i with covariates z i and x i , and the draws of θ i simulated from their posterior distribution during the Gibbs sampling would be recycled and used for the numerical integration of the factors.
Alternatively, the integration can be achieved sequentially by embedding the integration of the factors in the integration of model parameters:
Pr ∆ > 0|x, θ 
,
The number J of random draws determines the accuracy of the Monte Carlo integration of the latent factor. 13 In our simulation study, we compare results obtained from Monte Carlo integration with J = 100, J = 1, 000 and J = 10, 000 draws.
Simulation results
The three approaches described above are implemented to compute the distributional treatment effects. A posterior predictive approach is adopted and each of these treatment parameters is evaluated at the sample means z and x of the covariates Z and X of the future individual, respectively. Results are displayed in Tables 1 and 2 , where the means of the distributional treatment effects across the Monte Carlo replications, as well as the standard errors (SE), the biases and the root mean squared errors (RMSE) allow to compare the different estimators. Overall, the three approaches perform very well in estimating the treatment effects, and several interesting facts emerge. The quality of the results from the approaches based on the integration of the latent factor (MC2 and MC3) depends on the method used for the numerical integration. Integrating the latent factor simultaneously with model parameters (MC2) happens to perform as well as MC1, and better than the sequential integration carried out in MC3 if the number of draws J is not large enough for this latter one. Indeed, 100 draws from the distribution of θ provide the least accurate approximation, and this number has to be increased up to 10, 000 draws to reach the precision of MC2. 14 There is however a trade-off between the level of accuracy and computational burden in this case, and in this respect MC2 clearly appears more attractive than MC3. To summarize, estimators based on the compact forms of the treatment effects where the latent factors are integrated out should be favored in practice, whenever possible. They are simple to calculate. If the estimators based on the conditional model with the latent factors are preferred, then attention should be dedicated to the details of numerical integration. Our example shows that nesting the integration of latent factors and model parameters is only worthwhile with a large number of random draws for the Monte Carlo integration. These conclusions might however not be extended to more complicated models with multiple latent factors and/or more complicated functional forms than the simple continuous case presented here. Further research is therefore required to investigate the performances of the different estimators in these more general cases.
Conclusion
This paper discusses Bayesian approaches that address a fundamental identification problem arising in the analysis of treatment effects. It shows how treatment parameters can be alternatively computed in the framework of a potential outcomes factor structure model that generates identification of the covariance structure of the model by construction. In this approach, a variety of mean treatment effects and of their distributional versions can be derived. Depending on the needs of the analyst, different estimators can then easily be constructed to approximate these treatment effects. Our small simulation study illustrates the methodology and provides encouraging results. It also reveals that the choice of the estimator among those suggested might not be neutral. More systematic simulation studies should therefore be carried out to better investigate the behavior of these estimators in various contexts.
